Patexia Community

Innovation, Technology, and IP News

FDA Publishes Draft Medical Device Cybersecurity Guidance Amidst Continued Cybersecurity Concerns

On April 08, 2022, the Food and Drug Administration (FDA) published a draft cybersecurity guidance document for medical devices, titled Cybersecurity in Medical Devices: Quality...

Feed tagged as "HIV":
Nearly one million individuals with diabetes have to inject themselves daily with insulin. Patients with HIV and certain types of cancer also require frequent... Read More »
Scientists have highlighted the potential of a new technique that could act as a safer alternative to an experimental gene therapy against HIV infection. The... Read More »
Enjoy this week’s wrap up of trending medical news!   Rats paralyzed due to spinal cord injury walking again thanks to new therapy Rats that... Read More »
Diagnosing diseases such as HIV and leukemia could soon be as simple as screening cells using an inexpensive, portable device. The new chip can focus cells into a... Read More »
Daniel PorterI bet flow cytometry could be a useful technique in a variety of fields -- could they possibly implement a single FC device for a variety of applications?
May 30, 2012
Aurora SterlingI don't see why not. Seems like it would be fairly straightforward to adapt this for other uses.
May 30, 2012
Here’s the top medical news of this week! Promising new HIV treatments give hope for eventual cure   The Human Immunodeficiency Virus (HIV)... Read More »
Here’s your weekly roundup of hot medical news! Mending a broken heart with stem cells and microRNAs   Just like a deep wound causes a scar to... Read More »
A new study has proven the long-term success of treating HIV patients with genetically modified T cells. Patients who received infusions of their own T cells, which... Read More »
An international research team led by University of California, Davis has found that the World Health Organization's recommendation to flash-heat... Read More »
Researchers from University of California, Davis demonstrated the safety and efficacy of transplanting anti-HIV stem cells into mouse models in a new study. The... Read More »
The Lancet recently published new results from the Breastfeeding, Antiretrovirals, and Nutrition (BAN) trial conducted between 2004 and 2010 in Malawi. The current... Read More »
Stanford University researchers have published a study on the cost effectiveness of a once-daily drug in reducing the risk of HIV infection through a prevention... Read More »
Researchers at Wistar Institute and the University of Massachusetts, Amherst, with global collaborators, introduce a new "prediction-based classification"... Read More »
Researchers from University of California, Los Angeles (UCLA) and a joint research venture by the US Army and the National Institute of Allergy and Infectious... Read More »
Jackie KellyThanks for this article. So nice to have an examination of the complexities of fighting this disease.
Apr 15, 2012
A research team from UCLA has demonstrated that stem cells that were genetically engineered into HIV-fighting cells can attack HIV cells in living organisms... Read More »
Insights into how the first vaccine ever reported to modestly prevent HIV infection might have worked were published online today in the New England Journal of... Read More »
A new research report shows why the development of treatments for HIV has been so difficult. The report explains how Jack da Silva, author of the study, used computer ... Read More »
Results from a study released today show that HIV rates among African American women are much higher than previous estimates. The HPTN 064 Women's HIV... Read More »
Chemists at The University of Texas at Austin have developed a 3-D paper sensor that may be able to test for diseases such as malaria and HIV for less than 10 cents a ... Read More »
A team of researchers at the University of North Carolina at Chapel Hill have successfully brought latent HIV infection out of hiding, with a drug used to treat... Read More »
Gilead Sciences, Inc. has announced full Phase 3 clinical trial results from a study demonstrating that the Quad, a once-daily single tablet regimen of elvitegravir... Read More »
Show more Newsfeed posts